全球心脏映射市场 – 行业趋势和 2029 年预测

心脏映射市场分析和规模

心脏映射用于区分正常和异常心率的作用，以便提供准确的诊断治疗，并识别心律失常，以便提供准确的治疗。预计整个预测期内市场将增长更快。

Data Bridge Market Research 分析，心脏测绘市场规模在 2021 年为 8.6089 亿美元，到 2029 年将飙升至 18.8604 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 10.3%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

心脏映射市场范围和细分      

市场定义

Cardia mapping is a general word that refers to a variety of mapping techniques, including body surface mapping, endocardial mapping, and epicardial mapping, among others. Identification of the temporal and unique distribution of the myocardial electric potential during a certain heart rhythm is known as cardiac mapping. In particular, mapping refers to understanding the cardiac rhythm or clarifying the workings of the cardiovascular system.

Cardiac Mapping Market Dynamics

Drivers

• Increase in prevalence of cardiac conditions

The prevalence of conditions like an atrial flutter, which is characterized by abnormally rapid heartbeats also known as supraventricular tachycardia, is increasing and boosting the market for cardiac mapping. Due to the prevalence of atrial flutter, cardiac mapping is primarily performed using radiofrequency catheters, driving the market's expansion.

• Growing population of geriatrics

The substantial prevalence of the cardiac mapping market throughout the forecast period of 2022 to 2029 has been greatly aided by the growing population of geriatrics, the elderly, and people who have chronic heart conditions. And also the technology improvements are helping the cardiac mapping market expand in new economies.

• Technological Innovations

Growing technologies will probably accelerate market expansion during the anticipated term. As new technologies enter the market, existing therapy options are being replaced with ones that provide faster results, better precision and efficacy, and cover arrhythmia. With the aid of non-fluoroscopy catheter navigation, the most recent technologies are introduced with little exposure to ionising radiation (fluoroscopy). In order to provide patients with improved treatment alternatives that are financially feasible, these reasons are likely to encourage hospital doctors to adopt new technologies. Therefore, these elements are likely to boost the market.

Opportunities

In the forecast period, it is anticipated that the adoption of a variety of cutting-edge diagnostic technologies by medical device companies, the rise in demand for accurate cardiac disease diagnosis, and the accessibility of interventional cardiologists with the necessary training in developing economies will all contribute to the growth of the market for cardiac mapping systems.

Restraints/Challenges

During the period of growth, the cardiac mapping market is exposed to some restraining factors which can hinder the market expansion, such as undefined healthcare transformation and dearth of trained professionals to handle the electrophysiology.

This cardiac mapping market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac mapping market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Cardiac Mapping Market

The market for cardiac mapping is expanding as a result of the COVID-19 disease pandemic. According to a research project titled "Cardiac Involvement of COVID-19: A Comprehensive Review" published in January 2021, COVID-19 can significantly affect patients' cardiovascular systems. Diabetes, hypertension, and cardiovascular disease all significantly increase the risk of dying from COVID-19. Therefore, patients with CVDs must take all necessary precautions to avoid COVID-19, which may require cardiac mapping.

Recent Development

• In January 2022, Affera, Inc., a privately held medical technology business in the Boston region, will be acquired by Medtronic plc, a leader in worldwide healthcare technology. The cardiac mapping and navigation systems are created and produced by Affera.
• In January 2022,  Abbott received FDA approval for its EnSite X EP with EnSite Omnipolar technology. EnSite X EP creates detailed three-dimensional maps of the heart to help medical professionals locate and treat the regions of the organ where abnormal rhythms arise.

Global Cardiac Mapping Market Scope

The cardiac mapping market is segmented on the basis of indication, system. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

• Atrial Fibrillation
• Atrial Flutter
• AVNRT

 System

• Contact Cardiac Mapping Systems
• Non-contact Cardiac Mapping Systems

Cardiac Mapping Market Regional Analysis/Insights

The cardiac mapping market is analysed and market size insights and trends are provided by country, indication, system as referenced above.

心脏测绘市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的亚太地区其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷以及南美洲的其他地区。

由于政府机构大量提供研究资金援助，北美在心脏测绘市场占据主导地位。

 亚太地区（APAC）由于老年人口比例的连续性、心脏映射服务的丰厚补偿政策而正在崛起。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和心脏映射市场份额分析

心脏测绘市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对心脏测绘市场的关注有关。

心脏测绘市场的一些主要参与者包括：

• Biosense Webster（美国）
• 雅培（美国）
• 波士顿科学公司 (美国)
• 美敦力（爱尔兰）
• 微创医疗科学有限公司 (中国)
• EP Solutions（瑞士）
• Acutus Medical Inc.（美国）
• Koninklijke Philips NV（荷兰）
• 乐普医疗科技有限公司 (中国)
• BIOTRONIK（德国）
• AngioDynamics（美国）
• BioSig Technologies（美国）
• APN 健康（美国）
• CoreMap（美国）
• Kardium（加拿大）
• Catheter Precision（美国）
• Epmap系统（德国）

SKU-52783